A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Risk reduction surgery (RRS) for tubo-ovarian cancer in an Irish gynaecological practice: an analysis of indications and outcomes.
Claire Thompson, Ciara McCormick, Waseem Kamran, Ciaran O'Riain, Lucy Norris, David Gallagher, Noreen Gleeson. Ir J Med Sci 2018
6
100

Serous tubal intraepithelial neoplasia: the concept and its application.
Emily E K Meserve, Jan Brouwer, Christopher P Crum. Mod Pathol 2017
39
100

Incidence and Characteristics of Unsuspected Neoplasia Discovered in High-Risk Women Undergoing Risk Reductive Bilateral Salpingooophorectomy.
Carolin Poon, Simon Hyde, Peter Grant, Marsali Newman, Kerryn Ireland Jenkin. Int J Gynecol Cancer 2016
9
100

Prophylactic salpingectomy for prevention of ovarian cancer at the time of elective laparoscopic cholecystectomy.
G Tomasch, M Lemmerer, S Oswald, S Uranitsch, C Schauer, A-M Schütz, B Bliem, A Berger, P F J Lang, G Rosanelli,[...]. Br J Surg 2020
8
100

Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study.
Kala Visvanathan, Russell Vang, Patricia Shaw, Amy Gross, Robert Soslow, Vinita Parkash, Ie-Ming Shih, Robert J Kurman. Am J Surg Pathol 2011
99
100

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.
Ahmed Ashour Ahmed, Dariush Etemadmoghadam, Jillian Temple, Andy G Lynch, Mohamed Riad, Raghwa Sharma, Colin Stewart, Sian Fereday, Carlos Caldas, Anna Defazio,[...]. J Pathol 2010
446
100

High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy.
Jane E Hirst, Gregory B Gard, Kirsty McIllroy, David Nevell, Michael Field. Int J Gynecol Cancer 2009
48
100

Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.
Welmoed Reitsma, Geertruida H de Bock, Jan C Oosterwijk, Joost Bart, Harry Hollema, Marian J E Mourits. Eur J Cancer 2013
73
100

Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers.
Mae Zakhour, Yael Danovitch, Jenny Lester, B J Rimel, Christine S Walsh, Andrew J Li, Beth Y Karlan, Ilana Cass. Gynecol Oncol 2016
45
100

p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Karoline Leonhardt, Jens Einenkel, Sindy Sohr, Kurt Engeland, Lars-Christian Horn. Int J Gynecol Pathol 2011
37
100

Impact of risk-reducing salpingo-oophorectomy in premenopausal women.
R F M Vermeulen, M van Beurden, C M Korse, G G Kenter. Climacteric 2017
21
100

A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers.
Ilana Cass, Ann E Walts, Denise Barbuto, Jenny Lester, Beth Karlan. Gynecol Oncol 2014
20
100

Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
Sarah E Dilley, Laura J Havrilesky, Jamie Bakkum-Gamez, David E Cohn, J Michael Straughn, Aaron B Caughey, Maria I Rodriguez. Gynecol Oncol 2017
27
100

Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up.
F Blok, S Dasgupta, W N M Dinjens, E M Roes, H J van Beekhuizen, P C Ewing-Graham. Gynecol Oncol 2019
8
100

Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study.
L Minig, S Cabrera, R Oliver, A Couso, M J Rubio, S Iacoponi, M B Martin-Salamanca, S Carballo-Rastrilla, J M Cádenas-Rebollo, A García-Garcia,[...]. Clin Transl Oncol 2018
7
100

Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
Wouter Bulten, Hans Pinckaers, Hester van Boven, Robert Vink, Thomas de Bel, Bram van Ginneken, Jeroen van der Laak, Christina Hulsbergen-van de Kaa, Geert Litjens. Lancet Oncol 2020
99
100

Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma.
Russell Vang, Kala Visvanathan, Amy Gross, Emily Maambo, Mamta Gupta, Elisabetta Kuhn, Rose Fanghong Li, Brigitte M Ronnett, Jeffrey D Seidman, Anna Yemelyanova,[...]. Int J Gynecol Pathol 2012
82
100

Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma.
Martin Köbel, Anna M Piskorz, Sandra Lee, Shuhong Lui, Cecile LePage, Francesco Marass, Nitzan Rosenfeld, Anne-Marie Mes Masson, James D Brenton. J Pathol Clin Res 2016
159
100

Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer.
Y C Lee, M Bressel, P Grant, P Russell, C Smith, S Picken, S Camm, B E Kiely, R L Milne, S A McLachlan,[...]. Fam Cancer 2017
2
100


An Alternate Diagnostic Algorithm for the Diagnosis of Intraepithelial Fallopian Tube Lesions.
Marie E Perrone, Nicholas P Reder, Sergay N Agoff, Rochelle L Garcia, Kathy J Agnew, Barbara M Norquist, Kathryn P Pennington, Elizabeth M Swisher, Mark R Kilgore. Int J Gynecol Pathol 2020
2
100

Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.
Lauren C Peres, Kara L Cushing-Haugen, Martin Köbel, Holly R Harris, Andrew Berchuck, Mary Anne Rossing, Joellen M Schildkraut, Jennifer A Doherty. J Natl Cancer Inst 2019
127
100

Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).
Stephanie L Wethington, Kay J Park, Robert A Soslow, Noah D Kauff, Carol L Brown, Fanny Dao, Ebunoluwa Otegbeye, Yukio Sonoda, Nadeem R Abu-Rustum, Richard R Barakat,[...]. Int J Gynecol Cancer 2013
67
100

Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers.
Maria L Carcangiu, Paolo Radice, Siranoush Manoukian, Gianbattista Spatti, Morena Gobbo, Valeria Pensotti, Rosella Crucianelli, Barbara Pasini. Int J Gynecol Pathol 2004
93
100

Effectiveness of risk-reducing salpingo-oophorectomy in preventing ovarian cancer in a high-risk French Canadian population.
Omar Moreira Bacha, Jean Gregoire, Katherine Grondin, Maria Isabel Edelweiss, Rachel Laframboise, Jacques Simard, Marie Plante. Int J Gynecol Cancer 2012
7
100

Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis.
Elisabetta Kuhn, Alan Meeker, Tian-Li Wang, Ann Smith Sehdev, Robert J Kurman, Ie-Ming Shih. Am J Surg Pathol 2010
92
100

The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study.
Vilius Rudaitis, Vismantas Mikliusas, Gediminas Januska, Povilas Jukna, Ugnius Mickys, Ramunas Janavicius. Eur J Obstet Gynecol Reprod Biol 2020
3
100

Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series.
Enzo Ricciardi, Federica Tomao, Giovanni Aletti, Luca Bazzurini, Luca Bocciolone, Sara Boveri, Fabio Landoni, Maria Teresa Lapresa, Matteo Maruccio, Gabriella Parma,[...]. Anticancer Res 2017
8
100

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Julie D Lamb, Rochelle L Garcia, Barbara A Goff, Pamela J Paley, Elizabeth M Swisher. Am J Obstet Gynecol 2006
66
100

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Usha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, Naveena Singh, Andy Ryan, Chloe Karpinskyj, Giulia Carlino, Julie Taylor, Susan K Massingham, Maria Raikou,[...]. Lancet 2021
18
100

Serous tubal intraepithelial carcinoma, chronic fallopian tube injury, and serous carcinoma development.
Karin Malmberg, Charlotta Klynning, Angelique Flöter-Rådestad, Joseph W Carlson. Virchows Arch 2016
6
100

The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients - Slovenian population based study.
Andreja Gornjec, Sebastijan Merlo, Srdjan Novakovic, Vida Stegel, Barbara Gazic, Andraz Perhavec, Ana Blatnik, Mateja Krajc. Radiol Oncol 2020
1
100


Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls.
Marjanka J J M Mingels, Thijs Roelofsen, Jeroen A W M van der Laak, Joanne A de Hullu, Maaike A P C van Ham, Leon F A G Massuger, Johan Bulten, Mijke Bol. Gynecol Oncol 2012
52
100

An international Ki67 reproducibility study.
Mei-Yin C Polley, Samuel C Y Leung, Lisa M McShane, Dongxia Gao, Judith C Hugh, Mauro G Mastropasqua, Giuseppe Viale, Lila A Zabaglo, Frédérique Penault-Llorca, John M S Bartlett,[...]. J Natl Cancer Inst 2013
367
100

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.
Patricia A Shaw, Marjan Rouzbahman, Ellen S Pizer, Melania Pintilie, Heather Begley. Mod Pathol 2009
138
100

TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions.
Elisabetta Kuhn, Robert J Kurman, Russell Vang, Ann Smith Sehdev, Guangming Han, Robert Soslow, Tian-Li Wang, Ie-Ming Shih. J Pathol 2012
234
100


Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications.
Joseph W Carlson, Elke A Jarboe, David Kindelberger, Marisa R Nucci, Michelle S Hirsch, Christopher P Crum. Int J Gynecol Pathol 2010
60
100

Opportunistic prophylactic salpingectomy for prevention of ovarian cancer: What do national societies advise?
Angelika Ntoumanoglou-Schuiki, Gordana Tomasch, Rene Laky, Nadja Taumberger, Vesna Bjelic-Radisic, Karl Tamussino. Eur J Obstet Gynecol Reprod Biol 2018
13
100

Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy.
C B Powell, E M Swisher, I Cass, J McLennan, B Norquist, R L Garcia, J Lester, B Y Karlan, L Chen. Gynecol Oncol 2013
62
100

Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.
James R Conner, Emily Meserve, Ellen Pizer, Judy Garber, Michael Roh, Nicole Urban, Charles Drescher, Bradley J Quade, Michael Muto, Brooke E Howitt,[...]. Gynecol Oncol 2014
56
100

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
Fabiola Medeiros, Michael G Muto, Yonghee Lee, Julia A Elvin, Michael J Callahan, Colleen Feltmate, Judy E Garber, Daniel W Cramer, Christopher P Crum. Am J Surg Pathol 2006
561
100

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.
Mark E Sherman, Marion Piedmonte, Phuong L Mai, Olga B Ioffe, Brigitte M Ronnett, Linda Van Le, Iouri Ivanov, Maria C Bell, Stephanie V Blank, Paul DiSilvestro,[...]. J Clin Oncol 2014
78
100

Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.
Shannon K Rush, Elizabeth M Swisher, Rochelle L Garcia, Kathryn P Pennington, Kathy J Agnew, Mark R Kilgore, Barbara M Norquist. Gynecol Oncol 2020
4
100

Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-Oophorectomy.
Annelise M Wilhite, Makinna C Oestreich, Megan Olson, Sabrina M Bedell, Danielle Westenberg, Ananta Bangdiwala, Salman Ikramuddin, Monica Sanchez-Avila, Robert D Madoff, Mahmoud A Khalifa,[...]. Obstet Gynecol 2019
5
100

5
100

Surfing the p53 network.
B Vogelstein, D Lane, A J Levine. Nature 2000
100

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.
C Bethan Powell, Lee-may Chen, Jane McLennan, Beth Crawford, Charles Zaloudek, Joseph T Rabban, Dan H Moore, John Ziegler. Int J Gynecol Cancer 2011
104
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.